Colorectal cancer, Blood Test

A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an agreement with the Abu Dhabi ...